Mexico to start phase III clinical trials for China’s Walvax COVID vaccine
Mexico plans to start phase III clinical trials for China’s Walvax Biotechnology’s COVID-19 vaccine on May 30 and 6,000 volunteers are expected to participate, foreign minister Marcelo Ebrard said on Tuesday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.